Please select the option that best describes you:

Do you alter your management of ADT in a patient with high-risk prostate cancer who is a transwoman receiving estradiol hormone therapy?  

Are there any complications to using LHRH agonists in patients using estrogen? 



Answer from: Radiation Oncologist at Community Practice
Sign in or Register to read more